证券代码：002267 证券简称：陕天然气 公告编号：2025-026 陕西省天然气股份有限公司（以下简称"公司"）第六届董事会第十九 次会议于 2025 年 6 月 30 日以通讯方式召开。召开本次会议的通知已于 2025 年 6 月 25 日以直接送达或电子邮件方式送达各位董事。会议应参加 表决董事 11 名，实际参加表决董事 11 名。会议的召开符合法律法规和《公 司章程》的有关规定。 审议通过《关于修订<董事会授权经理层管理办法>的议案》 陕西省天然气股份有限公司 第六届董事会第十九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 具体内容详见公司于 2025 年 7 月 1 日在指定媒体和巨潮资讯网披露 的《董事会授权经理层管理办法》。 表决结果：11 票同意，0 票反对，0 票弃权。 二、董事会会议审议情况 2 第六届董事会第十九次会议决议及签字页。 特此公告。 陕西省天然气股份有限公司 董 事 会 2025 年 7 月 1 日 同意该议案。 三、备查文件 1 ...

证券代码：002267 证券简称：陕天然气 公告编号：2025-025 陕西省天然气股份有限公司 2024年度分红派息实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、股东会审议通过利润分配方案情况 1.陕西省天然气股份有限公司（以下简称"公司"）2024年度利润分 配方案已经2025年5月23日召开的2024年年度股东大会审议通过，具体内 容为：以2024年12月31日总股本1,112,075,445股为基数，向全体股东每10 股派3.50元人民币现金（含税），共派发现金红利389,226,405.75元（含 税）。本次利润分配不送红股，不进行资本公积转增股本。 2.自利润分配方案披露至实施期间公司股本总额未发生变化。如自公 司利润分配方案披露至实施分红派息股权登记日期间，公司总股本发生 变动的，公司拟维持每股分配比例不变，相应调整分配总额。 3.本次实施的分配方案与股东大会审议通过的分配方案一致。 4.本次实施分配方案距离股东大会审议通过的时间未超过两个月。 二、本次实施的利润分配方案 1 公司2024年度利润分配方案为：以公司现有总股本1,1 ...

证券代码：002267 证券简称：陕天然气 公告编号：2025-024 陕西省天然气股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会未出现否决议案的情形。 2.本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）陕西省天然气股份有限公司（以下简称"公司"）2025 年第 二次临时股东大会现场会议于 2025 年 6 月 11 日 15:00 在位于西安经济技 术开发区 A1 区开元路 2 号的公司调度指挥中心大楼 12 楼会议室召开。 （二）本次会议以现场表决与网络表决相结合的方式召开。 （三）本次会议由公司董事会召集，公司董事长刘宏波先生主持，公 司董事会于 2025 年 5 月 27 日在指定媒体及巨潮资讯网刊登了《关于召开 2025 年第二次临时股东大会通知的公告》。会议召集、召开程序符合《公 司法》《上市公司治理准则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等相关法律法规、规范性文件以及《公 司章程》的规定。 1 ...

陕西省西安市太白南路 139 号云图中心十五层 邮编：710065 传真/Fax:029-88360129 北京市康达（西安）律师事务所 关于陕西省天然气股份有限公司 2025 年第二次临时股东大会 之 法律意见书 （2025）北京康达法意字 198 号 二〇二五年六月十一日 网址/website：http://www.kdxa.com 陕西省西安市太白南路 139 号云图中心十五层 邮编：710065 传真/Fax:029-88360129 北京市康达（西安）律师事务所 关于陕西省天然气股份有限公司 2025 年第二次临时股东大会 之 法律意见书 （2025）北京康达法意字 198 号 致：陕西省天然气股份有限公司 北京市康达（西安）律师事务所（以下简称"本所"）接受陕西省 天然气股份有限公司（以下简称"公司"）的委托，指派刘坚律师、陈 世欢律师出席公司 2025 年第二次临时股东大会（以下简称"本次股东 大会"），对本次股东大会的召开和表决程序进行了审核和见证，并出 具本法律意见书。 第一部分声明 席会议的人员资格和召集人资格、会议的表决程序和表决结果事项发 表法律意见，并不对有关会计、审计和资产评估等非 ...

Group 1 - The implementation of new dividend regulations has significantly enhanced the dividend awareness among listed companies in Shaanxi, establishing a stable, timely, and predictable normalization of dividend mechanisms [1] - In 2024, nearly 70% of listed companies in Shaanxi overcame substantial declines in net profits, distributing cash dividends totaling 24.3 billion yuan, maintaining a high level of dividend scale [2] - The overall dividend amount accounted for over 70% of the net profit in the region, a substantial increase of 25 percentage points [2] Group 2 - The dividend payout ratio reached 47% after excluding loss-making companies, reflecting a year-on-year increase of 7 percentage points, indicating a continuous rise in dividend levels [2] - Shaanxi Coal's annual dividend exceeded 13 billion yuan, with a payout ratio close to 60%, setting a benchmark in the Northwest region [2] - In 2024, 36 companies in Shaanxi implemented interim dividends, representing 44% of the total, ranking first in the country [2] Group 3 - Companies such as Shaanxi Coal have maintained cash dividends for five consecutive years, while 11 companies have consistently paid dividends for over ten years, establishing a long-term, stable, and sustainable shareholder return mechanism [3] - Companies are actively improving operations to balance development and returns, as seen with Fenghuo Electronics, which implemented cash dividends and share buybacks after turning its retained earnings positive [3] - Overall, Shaanxi listed companies are responding positively to the new dividend regulations, fulfilling their responsibilities and enhancing investor satisfaction [3]

Group 1 - Kaichun Co., Ltd. adjusted the share repurchase price limit from 26.625 yuan/share to 40 yuan/share, effective from June 10, 2025 [1] - Yipin Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, a Class 3 chemical drug used for sedation during anesthesia [1] - Bohui Innovation obtained a medical device registration certificate for HPV Genotyping Test Kit, used for qualitative detection of HPV DNA [1][2] Group 2 - Lingyi Zhi Zao's application for issuing convertible bonds and cash payment to acquire 66.46% of Jiangsu Kedasiteng Automotive Technology Co., Ltd. has been accepted by the Shenzhen Stock Exchange [3] - Kemin Food reported a 23.06% year-on-year increase in pig sales in May, with a total of 48,300 pigs sold [4][5] - Meian Sen decided to terminate the issuance of shares to specific objects due to market conditions and strategic considerations [6][7] Group 3 - Zhengbang Technology reported a 146.6% year-on-year increase in pig sales revenue in May, totaling 731 million yuan [9] - Yuanda Holdings plans to reduce the registered capital of its subsidiary from 73 million to 24.3 million USD to optimize asset structure [10] - East China Pharmaceutical's subsidiary received FDA approval for clinical trials of HDM1010 tablets for type 2 diabetes [12] Group 4 - Liangxin Co., Ltd. received a government subsidy of 14.1 million yuan, accounting for 4.52% of its audited net profit for 2024 [13] - Erkang Pharmaceutical's Vitamin B6 Injection passed the consistency evaluation for generic drugs [14] - New Industry received a patent certificate for an antibody related to anti-PIC detection, enhancing detection efficiency [16][15] Group 5 - Dongxing Medical signed a 6 million yuan technology development contract with Shanghai Jiao Tong University for collagen preparation processes [16] - Suchang Chai A's subsidiary will absorb and merge another subsidiary, adjusting internal equity structure [17] - Yibin Technology received a project designation notice from a domestic new energy vehicle company, with an estimated total sales of 256 million yuan over five years [18] Group 6 - Mingchen Health received a cash dividend of 20 million yuan from its subsidiary [19] - Hendi Pharmaceutical obtained a drug registration certificate for Ibuprofen Suspension, a common medication for children [19] - Huaren Pharmaceutical's subsidiary received a drug registration certificate for Dexmedetomidine Hydrochloride Injection, classified as a Category B drug under national medical insurance [20] Group 7 - Enwei Pharmaceutical obtained a renewed drug production license for six key products [21] - Xiaoming Co., Ltd. reported a 45.59% year-on-year increase in chicken product sales in May, totaling 23.25 million birds [23][24] - Shan Natural Gas successfully issued a 350 million yuan short-term financing bond with a 1.78% interest rate [25] Group 8 - Xidamen announced plans for board members to reduce their holdings by up to 581,000 shares [26] - Shentong Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [27] - Saintno Bio plans to distribute a cash dividend of 0.14 yuan per share and a capital increase of 0.4 shares per share [28] Group 9 - *ST King Kong's subsidiary received a debt transfer notice from its controlling shareholder, totaling 364 million yuan [29] - Foxit Software's executives plan to reduce their holdings by a total of 55,800 shares [30] - Youyou Green Energy plans to apply for a bank credit line of up to 1.5 billion yuan [31] Group 10 - Guoxing Optoelectronics plans to distribute a cash dividend of 0.5 yuan per 10 shares [32] - Guangxun Technology plans to distribute a cash dividend of 2.6 yuan per 10 shares [33] - Hanrui Cobalt plans to distribute a cash dividend of 1.5 yuan per 10 shares [35] Group 11 - Tigermed plans to distribute a cash dividend of 3 yuan per 10 shares [37] - Shenliang Holdings plans to distribute a cash dividend of 1.5 yuan per 10 shares [38] - Yishitong plans to distribute a cash dividend of 1 yuan per 10 shares [39]

Core Points - The company, Shaanxi Natural Gas Co., Ltd., has successfully registered and issued a short-term financing bond amounting to 1.5 billion yuan [1] - The bond issuance was approved during the fourth extraordinary shareholders' meeting held on December 30, 2022 [1] - The total amount of the bond issued was 350 million yuan, with an interest rate of 1.78% and a maturity period of 270 days [1] Summary by Sections Company Announcement - The company announced the successful issuance of the short-term financing bond, with the registration amount set at 1.5 billion yuan [1] - The bond, named "25 Shaanxi Natural Gas SCP001," has a maturity date of March 2, 2026 [1] - The main underwriter for this bond issuance was Shanghai Pudong Development Bank Co., Ltd. [1] Subscription Details - There were three compliant subscription applications, totaling 180 million yuan [1] - The highest subscription price was 1.78%, while the lowest was 1.68% [1] - The effective subscription amount matched the total issuance amount of 350 million yuan [1]

证券代码：002267 证券简称：陕天然气 公告编号：2025-023 | 主承销商 | 上海浦东发展银行股份有限公司 | | | | --- | --- | --- | --- | | | 申购情况 | | | | 合规申购家数 | 3 家 | 合规申购金额 | 1.8 亿元 | | 最高申购价位 | 1.78% | 最低申购价位 | 1.68% | | 有效申购家数 | 3 家 | 有效申购金额 | 1.8 亿元 | | 簿记管理人 | 上海浦东发展银行股份有限公司 | | | 本 期 超 短 期 融 资 券 发 行 相 关 文 件 在 中 国 货 币 网 （www.chinamoney.com.cn）和上海清算所网站（www.shclearing.com.cn） 刊登。 经查询，截至本公告日，公司不是失信责任主体。 特此公告。 陕西省天然气股份有限公司 关于2025年度第一期超短期融资券发行结果的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚 假记载、误导性陈述或者重大遗漏。 陕西省天然气股份有限公司（以下简称"公司"）于 2022 年 12 月 13 日分别召开第五届董事会第二十六 ...

Investment Rating - The report assigns an "Accumulate" rating to the company [2][9] Core Viewpoints - The company is a leading operator of long-distance natural gas pipelines in Shaanxi Province, benefiting from high dividend yields and stable cash flows. The business model is characterized by a mix of stable pipeline transportation fees and city gas sales, with long-distance pipeline operations contributing 62.2% to revenue and 81.7% to gross profit in 2024 [6][9][11] - The company is expected to experience long-term growth driven by asset injections from the group and ongoing pipeline expansions. The acquisition of pipeline assets is anticipated to significantly increase gas sales volume, with a projected 70% year-on-year increase in gas sales volume in 2024 [6][9][11] - The company has a strong focus on shareholder returns, maintaining a dividend payout ratio above 60% from 2019 to 2024, with a projected dividend yield of approximately 5.6% based on the closing price on June 4, 2025 [6][9][29] Summary by Sections Company Overview - The company is controlled by Shaanxi Gas Group and is a major operator of long-distance natural gas pipelines in Shaanxi Province, with a pipeline network covering 4,569 kilometers and an annual gas transmission capacity of 17 billion cubic meters [12][54] Business Model - The primary business models include long-distance pipeline operations and city gas sales, with the former being the main profit contributor. The long-distance pipeline business operates on a stable fee structure, while city gas sales profit from the price difference between procurement and sales [16][19] Financial Performance - The company has shown stable revenue growth, with a compound annual growth rate (CAGR) of 11.5% in gas transmission volume from 2014 to 2024. The revenue for 2024 is projected to be 90.33 billion yuan, a 19.6% increase compared to the previous year [8][54][20] Growth Drivers - The company is expected to benefit from the injection of group assets and the completion of key pipeline projects, which will enhance its gas transmission capacity significantly. Two major pipelines under construction are projected to add substantial capacity upon completion [11][54] Market Position - The company holds a monopolistic position in the regional market, supported by high entry barriers and a stable operational framework. The government pricing mechanism ensures a steady cash flow linked to gas transmission volumes [50][51]

Investment Rating - The investment rating for the company is "Accumulate" [2][9] Core Views - The company is a leading operator of long-distance natural gas pipelines in Shaanxi Province, benefiting from high dividend yields and stable cash flows. The business model is primarily based on collecting stable pipeline transportation fees, with long-distance pipeline operations contributing 62.2% of revenue and 81.7% of gross profit in 2024. The company has maintained a dividend payout ratio above 60% from 2019 to 2024, with a projected dividend yield of approximately 5.6% based on the closing price on June 4, 2025 [6][9][29]. Summary by Sections Company Overview - The company is controlled by Shaanxi Gas Group and is a major operator of long-distance natural gas pipelines in Shaanxi Province. It has a well-established network covering most of the province, with a total pipeline length of 4,569 kilometers and an annual transportation capacity of 17 billion cubic meters [12][56]. Business Model - The main business segments include long-distance pipeline operations and urban gas distribution, with the former being the primary profit contributor. The long-distance pipeline business operates under a mixed model of unified purchase and sales plus transportation, while urban gas operations focus on the price difference between procurement and sales [16][19]. Financial Performance - The company has shown stable revenue growth, with a compound annual growth rate (CAGR) of 11.5% in gas transportation volume from 2014 to 2024. The revenue for 2024 is projected to be 90.33 billion yuan, a 19.6% increase compared to the previous year, driven by the acquisition of pipeline assets [20][56]. Growth Drivers - The company is expected to benefit from the injection of group assets and the construction of key pipelines, which will enhance its long-term growth potential. Two major pipelines under construction are projected to significantly increase the company's gas transportation capacity upon completion [11][56]. Market Demand - The natural gas demand in Shaanxi Province is expected to continue growing steadily, with residential gas consumption being a significant portion of the total demand. The province has abundant natural gas resources, with proven geological reserves of approximately 1.2 trillion cubic meters [38][41].